Published the 18 February 2021Invent Medic announces that the company has signed an agreement with MLVB Inc, a consultancy focused on assisting Swedish medical technology companies during expansion to the US market. This cooperation is expected to facilitate Invent Medic’s ongoing process to...
Regulatory
Published the 15 February 2021Invent Medic announces that the company has submitted an application to FDA for 510(k) market registration of the product Efemia bladder support in the United States. Invent Medic expects to be able to present marketing and sales plans for the product in the United...
Regulatory
Published the 11 February 2021The Board of Directors and the President will issue the following financial statements for the 2020 financial year. Unless otherwise specified, all amounts are reported in integers (SEK). Data in parentheses refer to the previous year. CEO Karin Bryder summarizes We...
Published the 25 January 2021Invent Medic announces that CEO Karin Bryder will present the company at the Swedish investor event Aktiedagen i Lund on January 27, 2021 at 9.15 CET. The event can be viewed live or on demand via Aktiespararna’s YouTube channel or via aktiespararna.se. Invent Medic’s...
Regulatory
Published the 14 December 2020Invent Medic announces that the company has signed a distribution agreement with Madrid-based En Suelo Firme, a company specialized in offering pelvic floor health products to Spanish-speaking women in Europe. En Suelo Firme has a strong social media presence, with...
